SEMINOLE COUNTY, Fla. — After the FDA’s decision to remove authorization for Regeneron’s use, an antibody infusion treatment center in Seminole County was able to continue treating patients with an ...

Please provide your email address to receive an email when new articles are posted on . A 500 mg intramuscular injection of sotrovimab was noninferior to an IV infusion of the investigational ...

PEORIA – Monoclonal antibodies, which continue to be an effective way to reduce the severity of COVID-19 infection, have evolved over the course of the pandemic. Just this week, the Food and Drug ...

TAMPA, Fla. — One monoclonal antibody treatment that health experts consider not to be useless against the omicron COVID-19 variant is offered to people in Hillsborough County at no cost. Through a ...

EL PASO, Texas (KFOX14) — People who visited El Paso's Regional Infusion Center on Wednesday were unable to be seen after the site temporarily closed on Monday due to a shortage of the Sotrovimab ...

BEAUMONT, Texas — The Southeast Texas Regional Infusion center is closed Wednesday after running out of Sotrovimab, a monoclonal antibody used to treat COVID-19. (EDITOR'S NOTE: The video above is ...

New Jersey hospitals have tightened access to COVID-19 monoclonal antibody treatments after the two previously leading therapies failed to work against the omicron variant and a newer, more effective ...

The supply of monoclonal antibodies has grown increasingly tight in Michigan as the omicron coronavirus variant spreads, pushing some health care systems to further restrict eligibility for a ...

SAN FRANCISCO, March 25, 2022 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the US Food and Drug Administration has amended the ...

Henry Ford Health System, based in Detroit, on Tuesday was down to its final 30 doses of monoclonal antibodies. This would have been exhausted by the end of the day. Before lunch, the six-hospital ...

The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...